chrX-111757759-A-G

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_001099922.3(ALG13):​c.3145A>G​(p.Asn1049Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,203,325 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1049S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000012 ( 0 hom. 10 hem. )

Consequence

ALG13
NM_001099922.3 missense

Scores

1
4
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.661

Publications

0 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12571305).
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000119 (13/1091894) while in subpopulation SAS AF = 0.000228 (12/52735). AF 95% confidence interval is 0.000131. There are 0 homozygotes in GnomAdExome4. There are 10 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAdExome4 at 10 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.3145A>G p.Asn1049Asp missense_variant Exon 26 of 27 ENST00000394780.8 NP_001093392.1 Q9NP73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.3145A>G p.Asn1049Asp missense_variant Exon 26 of 27 2 NM_001099922.3 ENSP00000378260.3 Q9NP73-1

Frequencies

GnomAD3 genomes
AF:
0.00000897
AC:
1
AN:
111431
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000236
AC:
4
AN:
169475
AF XY:
0.0000343
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000119
AC:
13
AN:
1091894
Hom.:
0
Cov.:
30
AF XY:
0.0000279
AC XY:
10
AN XY:
357988
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26165
American (AMR)
AF:
0.00
AC:
0
AN:
34239
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19057
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30098
South Asian (SAS)
AF:
0.000228
AC:
12
AN:
52735
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40435
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4053
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
839269
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45843
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000897
AC:
1
AN:
111431
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33613
show subpopulations
African (AFR)
AF:
0.0000326
AC:
1
AN:
30653
American (AMR)
AF:
0.00
AC:
0
AN:
10409
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3542
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2658
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5982
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
235
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53126
Other (OTH)
AF:
0.00
AC:
0
AN:
1496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 36 Uncertain:1
Aug 13, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces asparagine with aspartic acid at codon 1049 of the ALG13 protein (p.Asn1049Asp). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and aspartic acid. This variant is present in population databases (rs759347694, ExAC 0.01%). This missense change has been observed in individual(s) with clinical features of ALG13-related disease (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.68
D;.;.;.;.
FATHMM_MKL
Benign
0.63
D
LIST_S2
Benign
0.60
T;T;.;T;.
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.13
T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
2.0
M;.;.;.;.
PhyloP100
0.66
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-2.7
D;.;D;.;.
REVEL
Benign
0.039
Sift
Pathogenic
0.0
D;.;D;.;.
Sift4G
Uncertain
0.019
D;D;T;T;T
Polyphen
0.46
P;P;P;P;P
Vest4
0.095
MutPred
0.30
Loss of sheet (P = 0.0357);.;.;.;.;
MVP
0.64
MPC
0.35
ClinPred
0.35
T
GERP RS
-0.42
Varity_R
0.47
gMVP
0.20
Mutation Taster
=99/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759347694; hg19: chrX-111000987; API